Matthew Caufield Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Matthew Caufield

Stock Analyst at HC Wainwright & Co.

(4.63)
# 1402
Out of 5,504 analysts
174
Total ratings
Success rate
Average return

26 Stocks

Name Action PT Current % Upside Ratings Updated
IMUX Immunic
Reiterates: Buy
10 10
0.97 930.93% 5 Sep 26, 2025
ADVM Adverum Biotechnolog...
Reiterates: Buy
30 30
5.38 457.62% 7 Sep 23, 2025
FBLG FibroBiologics
Reiterates: Buy
10 10
0.55 1718.18% 6 Sep 12, 2025
MLYS Mineralys Therapeuti...
Reiterates: Buy
42 42
38.08 10.29% 11 Sep 8, 2025
KOD Kodiak Sciences
Maintains: Neutral
3 5
15.11 -66.91% 5 Aug 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
12 12
7.07 69.73% 7 Aug 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
16 16
6.97 129.56% 9 Aug 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
48 56
48.89 14.54% 7 Aug 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.92 316.67% 4 Jun 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
10
5.25 90.48% 1 Jun 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
12.21 63.8% 10 Jun 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
8
2.83 182.69% 1 Jun 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 9 May 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
72
65.08 10.63% 1 May 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9 9
n/a n/a 8 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
5.74 74.22% 13 May 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30 30
21.79 37.68% 3 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
32 32
13.73 133.07% 3 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
n/a n/a 6 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12 2
n/a n/a 7 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
2 2
11.04 -81.88% 16 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
36 36
8.56 320.56% 18 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
n/a n/a 9 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
28
365.77 -92.34% 1 Aug 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
35 40
n/a n/a 6 May 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
n/a n/a 1 Jul 18, 2022